{"id":"W3127659442","doi":"10.1101/2021.02.01.21250769","title":"Sarilumab treatment of hospitalised patients with severe or critical COVID-19: a multinational, randomised, adaptive, phase 3, double-blind, placebo-controlled trial","year":2021,"lang":"en","type":"preprint","venue":"medRxiv","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"University of Wisconsin-Madison; Regeneron Pharmaceuticals; Sanofi","keywords":"Medicine; Clinical endpoint; Placebo; Adverse effect; Internal medicine; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001313223,0.0008284411,0.003747594,0.0004231256,0.0002187097,0.00008138633,0.0003576732,0.0005185406,0.001324898],"category_scores_gemma":[0.09915876,0.0005120317,0.001152557,0.0003962862,0.0007516588,0.00009949529,0.0005050887,0.0007743306,0.00001139178],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001214057,"about_ca_system_score_gemma":0.00764425,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003030445,"about_ca_topic_score_gemma":0.00009495518,"domain_scores_codex":[0.9929305,0.000791604,0.001812709,0.001478308,0.002289195,0.000697672],"domain_scores_gemma":[0.9672292,0.02732657,0.0007198814,0.001242945,0.00225005,0.00123129],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9683524,0.01853639,0.005466262,0.00126214,0.003742256,0.0005546558,0.0007355257,0.0002910385,0.00001034297,0.00003848009,0.0001447289,0.0008658004],"study_design_scores_gemma":[0.9774988,0.01546264,0.0009900345,0.0005248206,0.002371569,0.000002368146,0.0001481132,0.001597545,0.00006884815,0.0000442629,0.0008024527,0.0004886059],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9621958,0.0003872216,0.002060081,0.00576358,0.0006295039,0.02810406,0.0004449498,0.0001184192,0.0002963758],"genre_scores_gemma":[0.9869111,0.0004119837,0.001527398,0.000535573,0.0004541036,0.008378789,0.0006200008,0.00008718189,0.001073874],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09784554,"threshold_uncertainty_score":0.9997332,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1013100771701962,"score_gpt":0.4473318526372725,"score_spread":0.3460217754670764,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}